BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shin JW, Chung YH. Molecular targeted therapy for hepatocellular carcinoma: Current and future. World J Gastroenterol 2013; 19(37): 6144-6155 [PMID: 24115810 DOI: 10.3748/wjg.v19.i37.6144]
URL: https://www.wjgnet.com/1007-9327/full/v19/i37/6144.htm
Number Citing Articles
1
Soo Hyung Ryu, Myoung Kuk Jang, Woo Jean Kim, Danbi Lee, Young-Hwa Chung. Metastatic tumor antigen in hepatocellular carcinoma: golden roads toward personalized medicineCancer and Metastasis Reviews 2014; 33(4): 965 doi: 10.1007/s10555-014-9522-4
2
Jiangfeng Hu, Chenlin Song, Bensong Duan, Xiaoyan Zhang, Dongliang Li, Liang Zhu, Hengjun Gao. LncRNA-SVUGP2 suppresses progression of hepatocellular carcinomaOncotarget 2017; 8(58): 97835 doi: 10.18632/oncotarget.18279
3
Paul R. Massey, Jonathan S. Okman, Julia Wilkerson, Edward W. Cowen. Tyrosine kinase inhibitors directed against the vascular endothelial growth factor receptor (VEGFR) have distinct cutaneous toxicity profiles: a meta-analysis and review of the literatureSupportive Care in Cancer 2015; 23(6): 1827 doi: 10.1007/s00520-014-2520-9
4
Bénédicte Delire, Peter Stärkel. The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implicationsEuropean Journal of Clinical Investigation 2015; 45(6): 609 doi: 10.1111/eci.12441
5
Junyu Huo, Jinzhen Cai, Liqun Wu. Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinomaCancer Medicine 2023; 12(1): 898 doi: 10.1002/cam4.4858
6
Bin Wei, Chunmei Guo, Shuqing Liu, Ming-Zhong Sun. Annexin A4 and cancerClinica Chimica Acta 2015; 447: 72 doi: 10.1016/j.cca.2015.05.016
7
Bing Jiang, Longfei Feng, Tao Yang, Wenjing Guo, Yangyang Li, Tao Wang, Chengguang Liu, Haixiang Su. Combination of chloroquine diphosphate and salidroside induces human liver cell apoptosis via regulation of mitochondrial dysfunction and autophagyMolecular Medicine Reports 2022; 27(2) doi: 10.3892/mmr.2022.12924
8
Masayoshi Yamaguchi, Tomiyasu Murata, Joe W. Ramos. The calcium channel agonist Bay K 8644 promotes the growth of human liver cancer HepG2 cells in vitro: suppression with overexpressed regucalcinMolecular and Cellular Biochemistry 2020; 472(1-2): 173 doi: 10.1007/s11010-020-03795-7
9
Ying Zheng, Xuemei Wang, Haidong Wang, Wei Yan, Quan Zhang, Xin Chang. Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathwayTumor Biology 2014; 35(6): 5189 doi: 10.1007/s13277-014-1673-y
10
Fengjie Xu, Runzhui Lin, Jianrui Liu, Zeming Chen, Hua Zhuo, Xingmu Liu, Dong-Hua Yang. Intravenous Immunoglobulin Inhibits Liver Cancer Progression by Promoting p38MAPK-Associated ApoptosisJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/1300989
11
Li-Hua Jiang, Ying-Li Hao, Jing-Wei Zhu. Expression and prognostic value of HER-2/neu, STAT3 and SOCS3 in hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology 2019; 43(3): 282 doi: 10.1016/j.clinre.2018.09.011
12
YUWU LIU, CHANG WU, YING WANG, SAILAN WEN, JUNPU WANG, ZHIHONG CHEN, QIONGQIONG HE, DEYUN FENG. Loss of plexin-B3 in hepatocellular carcinomaExperimental and Therapeutic Medicine 2015; 9(4): 1247 doi: 10.3892/etm.2015.2243
13
Prashant Sukharamwala, Daniel Hennessey, Thomas Wood, Shelly Singh, Carrie Ryan, Alexander Rosemurgy. Molecular profiles in foregut oncologyCancer Genetics 2016; 209(12): 537 doi: 10.1016/j.cancergen.2016.09.008
14
Zhi-guang Fu, Li Wang, Hong-yong Cui, Jian-long Peng, Shi-jie Wang, Jie-jie Geng, Ji-de Liu, Fei Feng, Fei Song, Ling Li, Ping Zhu, Jian-li Jiang, Zhi-nan Chen. A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cellsOncotarget 2016; 7(8): 9429 doi: 10.18632/oncotarget.6990
15
Hua Li, Qian Miao, Chun-wei Xu, Jian-hui Huang, Yue-fen Zhou, Mei-juan Wu. OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK PathwayJournal of Korean Medical Science 2016; 31(8): 1215 doi: 10.3346/jkms.2016.31.8.1215
16
Zhao-Shan Niu, Xiao-Jun Niu, Wen-Hong Wang. Genetic alterations in hepatocellular carcinoma: An updateWorld Journal of Gastroenterology 2016; 22(41): 9069-9095 doi: 10.3748/wjg.v22.i41.9069
17
Huimin Shen, Hao Wu, Fengkai Sun, Jianni Qi, Qiang Zhu. A novel four-gene of iron metabolism-related and methylated for prognosis prediction of hepatocellular carcinomaBioengineered 2021; 12(1): 240 doi: 10.1080/21655979.2020.1866303
18
Maria Daoudaki, Ioannis Fouzas. Hepatocellular carcinomaWiener Medizinische Wochenschrift 2014; 164(21-22): 450 doi: 10.1007/s10354-014-0296-7
19
Athina Kladi-Skandali, Kleita Michaelidou, Andreas Scorilas, Konstantinos Mavridis. Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/319861
20
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, MAKOTO SUEISHI. Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cellsOncology Letters 2014; 8(5): 2023 doi: 10.3892/ol.2014.2484
21
Danbi Lee, Myoung-Kuk Jang, Ji Hae Seo, Soo Hyung Ryu, Jeong A. Kim, Young-Hwa Chung. ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implicationsExperimental & Molecular Medicine 2018; 50(7): 1 doi: 10.1038/s12276-018-0106-1
22
Peng Lyu, Fengyue Li, Runzhi Deng, Qiliang Wei, Bingkai Lin, Lei Cheng, Bixing Zhao, Zhonglei Lu. Lnc-PIK3R1, transcriptionally suppressed by YY1, inhibits hepatocellular carcinoma progression via the Lnc-PIK3R1/miR-1286/GSK3β axisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(6): 167233 doi: 10.1016/j.bbadis.2024.167233
23
Gokhan Yildiz. Integrated multi‑omics data analysis identifying novel drug sensitivity‑associated molecular targets of hepatocellular carcinoma cellsOncology Letters 2018;  doi: 10.3892/ol.2018.8634
24
Lunxu Li, Shilin Xia, Xueying Shi, Xu Chen, Dong Shang. The novel immune-related genes predict the prognosis of patients with hepatocellular carcinomaScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89747-7
25
Sana Ferroudj, Gokhan Yildiz, Mourad Bouras, Evin Iscan, Umut Ekin, Mehmet Ozturk. Role of Fanconi anemia/BRCA pathway genes in hepatocellular carcinoma chemoresistanceHepatology Research 2016; 46(12): 1264 doi: 10.1111/hepr.12675
26
Yong-Ru Liu, Rui-Xue Tang, Wen-Ting Huang, Fang-Hui Ren, Rong-Quan He, Li-Hua Yang, Dian-Zhong Luo, Yi-Wu Dang, Gang Chen. Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanismWorld Journal of Hepatology 2015; 7(28): 2781-2791 doi: 10.4254/wjh.v7.i28.2781
27
Gloria C. Bonel-Pérez, Amalia Pérez-Jiménez, Isabel Gris-Cárdenas, Alberto M. Parra-Pérez, José Antonio Lupiáñez, Fernando J. Reyes-Zurita, Eva Siles, René Csuk, Juan Peragón, Eva E. Rufino-Palomares. Antiproliferative and Pro-Apoptotic Effect of Uvaol in Human Hepatocarcinoma HepG2 Cells by Affecting G0/G1 Cell Cycle Arrest, ROS Production and AKT/PI3K Signaling PathwayMolecules 2020; 25(18): 4254 doi: 10.3390/molecules25184254
28
Justin T. Huntington, Xing Tang, Lindsey N. Kent, Carl R. Schmidt, Gustavo Leone. The Spectrum of E2F in Liver Disease-Mediated Regulation in Biology and CancerJournal of Cellular Physiology 2016; 231(7): 1438 doi: 10.1002/jcp.25242
29
Jingwen Zhang, Ningning Wang, Xiaoxia Xie, Chunhong Yan, Fenghua Fu, Jianwen Yao, Hongbo Wang. Design, synthesis and biological activities of quinazoline containing sorafenib analogs as antitumor agentsWuhan University Journal of Natural Sciences 2017; 22(3): 239 doi: 10.1007/s11859-017-1241-6
30
Chang Min Kim, Shin Hwang, Bhumsuk Keam, Yun Suk Yu, Ji Hoon Kim, Dong-Sik Kim, Si Hyun Bae, Gun-Do Kim, Jong Kyu Lee, Yong Bae Seo, Soon Woo Nam, Koo Jeong Kang, Luigi Buonaguro, Jin Young Park, Yun Soo Kim, Hee Jung Wang. Gene Signature for Sorafenib Susceptibility in Hepatocellular Carcinoma: Different Approach with a Predictive BiomarkerLiver Cancer 2020; 9(2): 182 doi: 10.1159/000504548
31
Zhi-Peng Sun, Jian Zhang, Li-Hong Shi, Xiu-Rong Zhang, Yu Duan, Wen-Fang Xu, Gong Dai, Xue-Jian Wang. Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibitionBiomedicine & Pharmacotherapy 2015; 76: 65 doi: 10.1016/j.biopha.2015.10.023
32
Mirko Tarocchi, Simone Polvani, Giada Marroncini, Andrea Galli. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesisWorld Journal of Gastroenterology 2014; 20(33): 11630-11640 doi: 10.3748/wjg.v20.i33.11630
33
Jian Zhang, Chunyan Fang, Meihua Qu, Huina Wu, Xuejuan Wang, Hongan Zhang, Hui Ma, Zhaolin Zhang, Yongxue Huang, Lihong Shi, Shujuan Liang, Zhiqin Gao, Weiguo Song, Xuejian Wang. CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy AgentsFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01042
34
Priyadarshini Mohapatra, Natarajan Chandrasekaran. Wnt/β-catenin targeting in liver carcinoma through nanotechnology-based drug repurposing: A reviewBiomedicine & Pharmacotherapy 2022; 155: 113713 doi: 10.1016/j.biopha.2022.113713
35
Xiao‐Lan Wang, Min Shi, Tian Xiang, Yan‐Zhi Bu. Long noncoding RNA DGCR5 represses hepatocellular carcinoma progression by inactivating Wnt signaling pathwayJournal of Cellular Biochemistry 2019; 120(1): 275 doi: 10.1002/jcb.27342
36
Thomas Couri, Anjana Pillai. Goals and targets for personalized therapy for HCCHepatology International 2019; 13(2): 125 doi: 10.1007/s12072-018-9919-1
37
Masayoshi Yamaguchi, Satoru Osuka, M. Neale Weitzmann, Bassel F. El-Rayes, Mamoru Shoji, Tomiyasu Murata. Prolonged survival in hepatocarcinoma patients with increased regucalcin gene expression: HepG2 cell proliferation is suppressed by overexpression of regucalcin in vitroInternational Journal of Oncology 2016; 49(4): 1686 doi: 10.3892/ijo.2016.3669
38
Bingling Dai, Yujiao Ma, Tianfeng Yang, Mengying Fan, Runze Yu, Qi Su, Hongying Wang, Feng Liu, Changhua Yang, Yanmin Zhang. Synergistic effect of berberine and HMQ1611 impairs cell proliferation and migration by regulating Wnt signaling pathway in hepatocellular carcinomaPhytotherapy Research 2019; 33(3): 745 doi: 10.1002/ptr.6267
39
Kai-Cai Liu, Wei-Fu Lv, Dong Lu, Yu-Lin Tan, Guo-Xiang Wang, Jia-Yin Dai, Xian-Hai Zhu, Bo Jiang, Shao-Bao Xu, Zong-Gen Gao, Chang-Sheng Shi, Ming-Xue Su. Comparing the Effectiveness and Safety of Sorafenib Plus TACE with Apatinib Plus Tace for Treating Patients with Unresectable Hepatocellular Carcinoma: A Multicentre Propensity Score Matching StudySSRN Electronic Journal 2021;  doi: 10.2139/ssrn.3959157
40
Qinggong Yuan, Yan Zhang, Junhui Li, Di Zhang, Wenbin Yang. Circ_TEX2 Functions as a Tumor Suppressor in Hepatoma via miR-96-5p/SPRED1 AxisMolecular Biotechnology 2023; 65(10): 1679 doi: 10.1007/s12033-023-00669-3
41
Qianhui Chen, Xinyu Lu, Jiayi Xie, Na Ma, Weikang Xu, Zhiming Zhang, Xuan Huang, Hongyan Liu, Jinlin Hou, Xiaoyong Zhang, Wei Zhu. Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular CarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.813275
42
Dallyla Jennifer Morais de Sousa, Kynnara Gabriella Feitosa de Oliveira, Irislene Costa Pereira, Glauto Tuquarre Melo do Nascimento, Clenio Oliveira Barrense, Jorddam Almondes Martins, Beatriz de Mello Pereira Rêgo, Tiago Eugênio Oliveira da Silva, Felipe Cavalcanti Carneiro da Silva, Francisco Leonardo Torres-Leal. Dietary restriction and hepatic cancer: Systematic review and meta-analysis of animal studiesCritical Reviews in Oncology/Hematology 2024; 196: 104264 doi: 10.1016/j.critrevonc.2024.104264
43
LIMING CUI, BO GAO, ZHIGANG CAO, XIAOYING CHEN, SHIDE ZHANG, WEIZHE ZHANG. Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxideMolecular Medicine Reports 2016; 13(3): 2032 doi: 10.3892/mmr.2016.4757
44
Masayoshi Yamaguchi. Involvement of regucalcin as a suppressor protein in human carcinogenesis: insight into the gene therapyJournal of Cancer Research and Clinical Oncology 2015; 141(8): 1333 doi: 10.1007/s00432-014-1831-z
45
Gang Chen, Dongdong Wang, Xiongqi Zhao, Jun Cao, Yingpeng Zhao, Fan Wang, Jianhua Bai, Ding Luo, Li Li. miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signalingCancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0469-8
46
Helder Cardoso, Ana Margarida Alves, Margarida Marques, Ana Maria Vale, Pedro Pereira, Guilherme Macedo. Hepatocellular Carcinoma Treatment With Sorafenib: Real-Life Evaluation of Prognostic Factors and a Practical Clue for Patient ManagementGE Portuguese Journal of Gastroenterology 2016; 23(5): 243 doi: 10.1016/j.jpge.2016.04.006
47
Bo Hu, Xiao-Bo Yang, Xin-Ting Sang. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patientsInternational Immunopharmacology 2021; 90: 107164 doi: 10.1016/j.intimp.2020.107164
48
Liang Yin, Kai-Cai Liu, Wei-Fu Lv, Dong Lu, Yu-Lin Tan, Guo-Xiang Wang, Jia-Ying Dai, Xian-Hai Zhu, Bo Jiang. Comparing the effectiveness and safety of Sorafenib plus TACE with Apatinib plus TACE for treating patients with unresectable hepatocellular carcinoma: a multicentre propensity score matching studyCancer Imaging 2023; 23(1) doi: 10.1186/s40644-023-00574-7
49
Juhyun Kim, Ranhui Won, Guyee Ban, Mi Ha Ju, Kyung Sook Cho, Sang Young Han, Jin-Sook Jeong, Seong-Wook Lee. Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA RegulationScientific Reports 2015; 5(1) doi: 10.1038/srep12315
50
Jun Fujita, Toshiharu Sakurai. Human Cell TransformationAdvances in Experimental Medicine and Biology 2019; 1164: 63 doi: 10.1007/978-3-030-22254-3_5
51
Surabhi Pathak, Mohamad Sonbol. Second-Line Treatment Options for Hepatocellular Carcinoma: Current Landscape and Future DirectionJournal of Hepatocellular Carcinoma 2021; : 1147 doi: 10.2147/JHC.S268314
52
Yong He, Xiao-Ming Meng, Cheng Huang, Bao-Ming Wu, Lei Zhang, Xiong-Wen Lv, Jun Li. Long noncoding RNAs: Novel insights into hepatocelluar carcinomaCancer Letters 2014; 344(1): 20 doi: 10.1016/j.canlet.2013.10.021
53
Jun Wang, Li Gong, Shao-Jun Zhu, Qiao Zhu, Li Yao, Xiu-Juan Han, Jia-Rui Zhang, Yan-Hong Li, Wei Zhang, Diego Calvisi. The Human Homolog of Drosophila Headcase Acts as a Tumor Suppressor through Its Blocking Effect on the Cell Cycle in Hepatocellular CarcinomaPLOS ONE 2015; 10(9): e0137579 doi: 10.1371/journal.pone.0137579
54
Cholpajsorn Junhom, Natthida Weerapreeyakul, Waraporn Tanthanuch, Kanjana Thumanu. Partial least squares regression and fourier transform infrared (FTIR) microspectroscopy for prediction of resistance in hepatocellular carcinoma HepG2 cellsExperimental Cell Research 2017; 351(1): 82 doi: 10.1016/j.yexcr.2016.12.027
55
Sevil Uygun Ilikhan, Muammer Bilici, Hatice Sahin, Ayşe Semra Demir Akca, Murat Can, Ibrahim Ilker Oz, Berrak Guven, M Cagatay Buyukuysal, Yucel Ustundag. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(22): 6999-7007 doi: 10.3748/wjg.v21.i22.6999
56
Parvin Zamani, Maryam Matbou Riahi, Amir Abbas Momtazi-Borojeni, Khadijeh Jamialahmadi. Gankyrin: a novel promising therapeutic target for hepatocellular carcinomaArtificial Cells, Nanomedicine, and Biotechnology 2018; 46(7): 1301 doi: 10.1080/21691401.2017.1388250
57
Youming Ding, Xiaoyan Chen, Bin Wang, Bin Yu, Jianhui Ge, Xiaokang Shi. Quercetin suppresses the chymotrypsin-like activity of proteasome via inhibition of MEK1/ERK1/2 signaling pathway in hepatocellular carcinoma HepG2 cellsCanadian Journal of Physiology and Pharmacology 2018; 96(5): 521 doi: 10.1139/cjpp-2017-0655
58
Priyadarshini Mohapatra, Natarajan Chandrasekaran, Amitava Mukherjee. Handbook of Research on Nanoemulsion Applications in Agriculture, Food, Health, and Biomedical SciencesAdvances in Chemical and Materials Engineering 2022; : 307 doi: 10.4018/978-1-7998-8378-4.ch014
59
Stacey Prenner, Laura Kulik. Zakim and Boyer's Hepatology2018; : 668 doi: 10.1016/B978-0-323-37591-7.00046-X
60
Qianping Zhou, Lanshan Huang, Yongyao Gu, Huiping Lu, Zhenbo Feng. The expression of CCL18 in diffuse large B cell lymphoma and its mechanism researchCancer Biomarkers 2018; 21(4): 925 doi: 10.3233/CBM-171097
61
Masayoshi Yamaguchi, Tomiyasu Murata, Joe W. Ramos. The phytochemical p-hydroxycinnamic acid suppresses the growth and stimulates the death in human liver cancer HepG2 cellsAnti-Cancer Drugs 2021; 32(5): 558 doi: 10.1097/CAD.0000000000001059
62
Jianfeng Tian, Dengdi Hu. LncRNA SLC16A1-AS1 is upregulated in hepatocellular carcinoma and predicts poor survivalClinics and Research in Hepatology and Gastroenterology 2021; 45(2): 101490 doi: 10.1016/j.clinre.2020.07.001